March 19, 2024Open Access

Nascent matrix deposition supports alveolar organoid formation from aggregates in synthetic hydrogels

View Full Paper

Ask AI

Bookmark

Authors

MEMadeline K. EikenUniversity of Michigan CCCharlie J. ChildsUniversity of Michigan LBLindy K. BrastromUniversity of Michigan

Discussion

Member takes

Implication

In vitro study shows that nascent matrix deposition drives alveolar organoid growth in synthetic hydrogels, suggesting a defined platform to model human lung disease.

Key Points

Aggregated cellular clusters secrete their own nascent extracellular matrix to drive robust alveolar organoid growth, overcoming the traditional requirement for animal-derived Matrigel.
Pre-aggregation of induced pluripotent stem cells in microwells followed by synthetic hydrogel embedding establishes a defined culture system with tight biophysical control.
This hydrogel platform decouples exogenous signals from cell-secreted matrices to elucidate organoid formation pathways — in vitro organoid model; further preclinical work needed.

Cite This Study

Eiken et al. (2024) studied this question.

synapsesocial.com/papers/68e73613b6db6435876af25c https://doi.org/10.1101/2024.03.19.585720

View Full Paper

Ask AI

Bookmark

Implication

In vitro study shows that nascent matrix deposition drives alveolar organoid growth in synthetic hydrogels, suggesting a defined platform to model human lung disease.

Nascent matrix deposition supports alveolar organoid formation from aggregates in synthetic hydrogels

Discussion

Member takes

Implication

Key Points

Cite This Study

Nascent matrix deposition supports alveolar organoid formation from aggregates in synthetic hydrogels

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider